MeritValue

POMDOCTOR Ltd

POMdata completeness 100%1 fiscal years on file

Data notes: no data for concept 'investmentsAtFairValue'; no data for concept 'netInvestmentIncome'; no data for concept 'gainsOnRealEstateSales'; no data for concept 'dividendsPaid'

i. The business — what you’d actually own
FigureFY 2025
Revenue$57.2M1
Net income−$18.7M2
Operating cash flow−$21.2M3
Capital expenditure$144,1074
Free cash flow (derived)−$21.4M3
Total debt$19.3M5
Cash & equivalents$1.37M6
Diluted shares9.7M

Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).

ii. Your slice — ownership made literal
If you owned
shares
Net assets behind them
−$67.06
your share of equity
Profit it earned you last year
−$19.34
Free cash flow it threw off
−$22.08
Debt you’d be carrying
$19.92

10 shares is a claim on −$67.06 of net worth that earned you −$19.34 and generated −$22.08 of cash last year, against $19.92 of debt.

iii. Is this a good business?
Moat signal · return on equity
— avg · 1y

Not enough data in the filings for a return-on-capital reading.

seeing a moat in the numbers →
Management signal · capital allocation
−0% shares · 1y

Share count is roughly flat over 1 years — little dilution, little buyback. Total debt has held roughly steady.

reading capital allocation →

Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.

iv. What it’s worth — engine v0.5.0
DCF · Growth Exit 10Y
not applicable
only 1 years of FCF (need ≥3) — model not applicable
DCF · Growth Exit 5Y
not applicable
only 1 years of FCF (need ≥3) — model not applicable
Earnings Power Value
not applicable
only 1 years of net income (need ≥3)
Graham Number
not applicable
diluted EPS missing or non-positive — Graham Number undefined

Different models answer different questions — which to trust when →

Sources — the receipts
  1. 20-F · period ending 2025-12-31 · accession 0001213900-26-056576 (Revenues)
  2. 20-F · period ending 2025-12-31 · accession 0001213900-26-056576 (ProfitLoss)
  3. 20-F · period ending 2025-12-31 · accession 0001213900-26-056576 (NetCashProvidedByUsedInOperatingActivities)
  4. 20-F · period ending 2025-12-31 · accession 0001213900-26-056576 (PaymentsToAcquirePropertyPlantAndEquipment)
  5. 20-F · period ending 2025-12-31 · accession 0001213900-26-056576 (LongTermDebt)
  6. 20-F · period ending 2025-12-31 · accession 0001213900-26-056576 (CashAndCashEquivalentsAtCarryingValue)